Global Orphan Drugs Sales Market Report 2016

December 2016 | 119 pages | ID: G101A0560F0EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Orphan Drugs

Revenue, means the sales value of Orphan Drugs

This report studies sales (consumption) of Orphan Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Bristol-Mayers Squibb
• Norartis
• Celgene
• Roche
• Pfizer
• Alexion
• Sanofi
• Vertes
• GSK
• Merck
• Johnson& Johnson

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Orphan Drugs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• New molecular entities drugs
• Biologics drugs
• Other

Split by applications, this report focuses on sales, market share and growth rate of Orphan Drugs in each application, can be divided into

• Oncologic
• Metabolic
• Hematologic-immunologic
• Infections/ parasitic
• Other

Contents

Global Orphan Drugs Sales Market Report 2016

1 ORPHAN DRUGS OVERVIEW

1.1 Product Overview and Scope of Orphan Drugs
1.2 Classification of Orphan Drugs
  1.2.1 New molecular entities drugs
  1.2.2 Biologics drugs
  1.2.3 Other
1.3 Application of Orphan Drugs
  1.3.1 Oncologic
  1.3.2 Metabolic
  1.3.3 Hematologic-immunologic
  1.3.4 Infections/ parasitic
  1.3.5 Other
1.4 Orphan Drugs Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Orphan Drugs (2011-2021)
  1.5.1 Global Orphan Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Orphan Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL ORPHAN DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Orphan Drugs Market Competition by Manufacturers
  2.1.1 Global Orphan Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Orphan Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Orphan Drugs (Volume and Value) by Type
  2.2.1 Global Orphan Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Orphan Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Orphan Drugs (Volume and Value) by Regions
  2.3.1 Global Orphan Drugs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Orphan Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Orphan Drugs (Volume) by Application

3 UNITED STATES ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Orphan Drugs Sales and Value (2011-2016)
  3.1.1 United States Orphan Drugs Sales and Growth Rate (2011-2016)
  3.1.2 United States Orphan Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 United States Orphan Drugs Sales Price Trend (2011-2016)
3.2 United States Orphan Drugs Sales and Market Share by Manufacturers
3.3 United States Orphan Drugs Sales and Market Share by Type
3.4 United States Orphan Drugs Sales and Market Share by Application

4 CHINA ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Orphan Drugs Sales and Value (2011-2016)
  4.1.1 China Orphan Drugs Sales and Growth Rate (2011-2016)
  4.1.2 China Orphan Drugs Revenue and Growth Rate (2011-2016)
  4.1.3 China Orphan Drugs Sales Price Trend (2011-2016)
4.2 China Orphan Drugs Sales and Market Share by Manufacturers
4.3 China Orphan Drugs Sales and Market Share by Type
4.4 China Orphan Drugs Sales and Market Share by Application

5 EUROPE ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Orphan Drugs Sales and Value (2011-2016)
  5.1.1 Europe Orphan Drugs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Orphan Drugs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Orphan Drugs Sales Price Trend (2011-2016)
5.2 Europe Orphan Drugs Sales and Market Share by Manufacturers
5.3 Europe Orphan Drugs Sales and Market Share by Type
5.4 Europe Orphan Drugs Sales and Market Share by Application

6 JAPAN ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Orphan Drugs Sales and Value (2011-2016)
  6.1.1 Japan Orphan Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Orphan Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Orphan Drugs Sales Price Trend (2011-2016)
6.2 Japan Orphan Drugs Sales and Market Share by Manufacturers
6.3 Japan Orphan Drugs Sales and Market Share by Type
6.4 Japan Orphan Drugs Sales and Market Share by Application

7 GLOBAL ORPHAN DRUGS MANUFACTURERS ANALYSIS

7.1 Bristol-Mayers Squibb
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Orphan Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Bristol-Mayers Squibb Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Norartis
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 119 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Norartis Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Celgene
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 137 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Celgene Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Roche
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Roche Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Alexion
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Alexion Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Sanofi
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharmaceuticals Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Sanofi Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Vertes
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Vertes Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 GSK
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 GSK Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Merck
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Merck Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Johnson& Johnson

8 ORPHAN DRUGS MAUFACTURING COST ANALYSIS

8.1 Orphan Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Orphan Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Orphan Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Orphan Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ORPHAN DRUGS MARKET FORECAST (2016-2021)

12.1 Global Orphan Drugs Sales, Revenue Forecast (2016-2021)
12.2 Global Orphan Drugs Sales Forecast by Regions (2016-2021)
12.3 Global Orphan Drugs Sales Forecast by Type (2016-2021)
12.4 Global Orphan Drugs Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Orphan Drugs
Table Classification of Orphan Drugs
Figure Global Sales Market Share of Orphan Drugs by Type in 2015
Figure New molecular entities drugs Picture
Figure Biologics drugs Picture
Figure Other Picture
Table Applications of Orphan Drugs
Figure Global Sales Market Share of Orphan Drugs by Application in 2015
Figure Oncologic Examples
Figure Metabolic Examples
Figure Hematologic-immunologic Examples
Figure Infections/ parasitic Examples
Figure Other Examples
Figure United States Orphan Drugs Revenue and Growth Rate (2011-2021)
Figure China Orphan Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Orphan Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Orphan Drugs Revenue and Growth Rate (2011-2021)
Figure Global Orphan Drugs Sales and Growth Rate (2011-2021)
Figure Global Orphan Drugs Revenue and Growth Rate (2011-2021)
Table Global Orphan Drugs Sales of Key Manufacturers (2011-2016)
Table Global Orphan Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Orphan Drugs Sales Share by Manufacturers
Figure 2016 Orphan Drugs Sales Share by Manufacturers
Table Global Orphan Drugs Revenue by Manufacturers (2011-2016)
Table Global Orphan Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Orphan Drugs Revenue Share by Manufacturers
Table 2016 Global Orphan Drugs Revenue Share by Manufacturers
Table Global Orphan Drugs Sales and Market Share by Type (2011-2016)
Table Global Orphan Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Orphan Drugs by Type (2011-2016)
Figure Global Orphan Drugs Sales Growth Rate by Type (2011-2016)
Table Global Orphan Drugs Revenue and Market Share by Type (2011-2016)
Table Global Orphan Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Orphan Drugs by Type (2011-2016)
Figure Global Orphan Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Orphan Drugs Sales and Market Share by Regions (2011-2016)
Table Global Orphan Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Orphan Drugs by Regions (2011-2016)
Figure Global Orphan Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Orphan Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Orphan Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Orphan Drugs by Regions (2011-2016)
Figure Global Orphan Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Orphan Drugs Sales and Market Share by Application (2011-2016)
Table Global Orphan Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Orphan Drugs by Application (2011-2016)
Figure Global Orphan Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Orphan Drugs Sales and Growth Rate (2011-2016)
Figure United States Orphan Drugs Revenue and Growth Rate (2011-2016)
Figure United States Orphan Drugs Sales Price Trend (2011-2016)
Table United States Orphan Drugs Sales by Manufacturers (2011-2016)
Table United States Orphan Drugs Market Share by Manufacturers (2011-2016)
Table United States Orphan Drugs Sales by Type (2011-2016)
Table United States Orphan Drugs Market Share by Type (2011-2016)
Table United States Orphan Drugs Sales by Application (2011-2016)
Table United States Orphan Drugs Market Share by Application (2011-2016)
Figure China Orphan Drugs Sales and Growth Rate (2011-2016)
Figure China Orphan Drugs Revenue and Growth Rate (2011-2016)
Figure China Orphan Drugs Sales Price Trend (2011-2016)
Table China Orphan Drugs Sales by Manufacturers (2011-2016)
Table China Orphan Drugs Market Share by Manufacturers (2011-2016)
Table China Orphan Drugs Sales by Type (2011-2016)
Table China Orphan Drugs Market Share by Type (2011-2016)
Table China Orphan Drugs Sales by Application (2011-2016)
Table China Orphan Drugs Market Share by Application (2011-2016)
Figure Europe Orphan Drugs Sales and Growth Rate (2011-2016)
Figure Europe Orphan Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Orphan Drugs Sales Price Trend (2011-2016)
Table Europe Orphan Drugs Sales by Manufacturers (2011-2016)
Table Europe Orphan Drugs Market Share by Manufacturers (2011-2016)
Table Europe Orphan Drugs Sales by Type (2011-2016)
Table Europe Orphan Drugs Market Share by Type (2011-2016)
Table Europe Orphan Drugs Sales by Application (2011-2016)
Table Europe Orphan Drugs Market Share by Application (2011-2016)
Figure Japan Orphan Drugs Sales and Growth Rate (2011-2016)
Figure Japan Orphan Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Orphan Drugs Sales Price Trend (2011-2016)
Table Japan Orphan Drugs Sales by Manufacturers (2011-2016)
Table Japan Orphan Drugs Market Share by Manufacturers (2011-2016)
Table Japan Orphan Drugs Sales by Type (2011-2016)
Table Japan Orphan Drugs Market Share by Type (2011-2016)
Table Japan Orphan Drugs Sales by Application (2011-2016)
Table Japan Orphan Drugs Market Share by Application (2011-2016)
Table Bristol-Mayers Squibb Basic Information List
Table Bristol-Mayers Squibb Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Mayers Squibb Orphan Drugs Global Market Share (2011-2016)
Table Norartis Basic Information List
Table Norartis Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Norartis Orphan Drugs Global Market Share (2011-2016)
Table Celgene Basic Information List
Table Celgene Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Orphan Drugs Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Orphan Drugs Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Orphan Drugs Global Market Share (2011-2016)
Table Alexion Basic Information List
Table Alexion Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alexion Orphan Drugs Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Orphan Drugs Global Market Share (2011-2016)
Table Vertes Basic Information List
Table Vertes Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Vertes Orphan Drugs Global Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Orphan Drugs Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Orphan Drugs Global Market Share (2011-2016)
Table Johnson& Johnson Basic Information List
Table Johnson& Johnson Orphan Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson& Johnson Orphan Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Orphan Drugs
Figure Manufacturing Process Analysis of Orphan Drugs
Figure Orphan Drugs Industrial Chain Analysis
Table Raw Materials Sources of Orphan Drugs Major Manufacturers in 2015
Table Major Buyers of Orphan Drugs
Table Distributors/Traders List
Figure Global Orphan Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Orphan Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Orphan Drugs Sales Forecast by Regions (2016-2021)
Table Global Orphan Drugs Sales Forecast by Type (2016-2021)
Table Global Orphan Drugs Sales Forecast by Application (2016-2021)